| Thomas Edwards Carey, MD | |
|
5052 W 4th St, Hattiesburg, MS 39402-1069 | |
| (601) 261-2587 | |
| (601) 264-7426 |
| Full Name | Thomas Edwards Carey |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 34 Years |
| Location | 5052 W 4th St, Hattiesburg, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922132323 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 9557 (Montana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Merit Health River Oaks | Flowood, MS | Hospital |
| Merit Health Wesley | Hattiesburg, MS | Hospital |
| Merit Health Natchez | Natchez, MS | Hospital |
| Magee General Hospital | Magee, MS | Hospital |
| Crossgates River Oaks Hospital | Brandon, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hub Care Pathology, P.a. | 3173616240 | 9 |
News Archive
Adding the targeted therapy ribociclib to hormone therapy significantly improved overall survival (OS) in premenopausal patients with advanced hormone receptor-positive (HR+) breast cancer, according to results of the MONALEESA-7 Phase III clinical trial led by researchers at The University of Texas MD Anderson Cancer Center.
Absorption Systems, a leader in testing drugs for ADMET (absorption, distribution, metabolism, excretion and toxicity), today introduced an extensively renovated surgical suite for preclinical medical device testing at the company's facility in San Diego, CA. Absorption Systems has long been recognized as a leader in drug testing and is experiencing increased demand for its medical device testing services as well.
Patients undergoing treatment for advanced head and neck cancers may respond well to the addition of gefinitib to chemotherapy, according to a study sponsored by the Eastern Cooperative Oncology Group and chaired by Ethan Argiris, M.D., associate professor of medicine, University of Pittsburgh School of Medicine, and co-leader of the Head and Neck Cancer Program of the University of Pittsburgh Cancer Institute (UPCI).
The U.S. Department of Agriculture's (USDA) National Veterinary Services Laboratories (NVSL) in Ames, Iowa, has determined that the non-definitive test result reported on July 27 is negative for BSE. Tests conducted by the Veterinary Laboratories Agency in Weybridge, England, are also negative for BSE.
The older adult population in the United States is rapidly increasing, with 10,000 Americans reaching retirement age every day, but many face barriers when it comes to accessing oral healthcare. According to a survey conducted by Harris Poll on behalf of Oral Health America, more than half of low income older adults have not seen a dentist in the past year, with most citing lack of income or lack of dental insurance as the reason.
› Verified 6 days ago
| Entity Name | Hub Care Pathology, P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043324767 PECOS PAC ID: 3173616240 Enrollment ID: O20070905000545 |
News Archive
Adding the targeted therapy ribociclib to hormone therapy significantly improved overall survival (OS) in premenopausal patients with advanced hormone receptor-positive (HR+) breast cancer, according to results of the MONALEESA-7 Phase III clinical trial led by researchers at The University of Texas MD Anderson Cancer Center.
Absorption Systems, a leader in testing drugs for ADMET (absorption, distribution, metabolism, excretion and toxicity), today introduced an extensively renovated surgical suite for preclinical medical device testing at the company's facility in San Diego, CA. Absorption Systems has long been recognized as a leader in drug testing and is experiencing increased demand for its medical device testing services as well.
Patients undergoing treatment for advanced head and neck cancers may respond well to the addition of gefinitib to chemotherapy, according to a study sponsored by the Eastern Cooperative Oncology Group and chaired by Ethan Argiris, M.D., associate professor of medicine, University of Pittsburgh School of Medicine, and co-leader of the Head and Neck Cancer Program of the University of Pittsburgh Cancer Institute (UPCI).
The U.S. Department of Agriculture's (USDA) National Veterinary Services Laboratories (NVSL) in Ames, Iowa, has determined that the non-definitive test result reported on July 27 is negative for BSE. Tests conducted by the Veterinary Laboratories Agency in Weybridge, England, are also negative for BSE.
The older adult population in the United States is rapidly increasing, with 10,000 Americans reaching retirement age every day, but many face barriers when it comes to accessing oral healthcare. According to a survey conducted by Harris Poll on behalf of Oral Health America, more than half of low income older adults have not seen a dentist in the past year, with most citing lack of income or lack of dental insurance as the reason.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Thomas Edwards Carey, MD 5052 W 4th St, Hattiesburg, MS 39402-1069 Ph: (601) 261-2587 | Thomas Edwards Carey, MD 5052 W 4th St, Hattiesburg, MS 39402-1069 Ph: (601) 261-2587 |
News Archive
Adding the targeted therapy ribociclib to hormone therapy significantly improved overall survival (OS) in premenopausal patients with advanced hormone receptor-positive (HR+) breast cancer, according to results of the MONALEESA-7 Phase III clinical trial led by researchers at The University of Texas MD Anderson Cancer Center.
Absorption Systems, a leader in testing drugs for ADMET (absorption, distribution, metabolism, excretion and toxicity), today introduced an extensively renovated surgical suite for preclinical medical device testing at the company's facility in San Diego, CA. Absorption Systems has long been recognized as a leader in drug testing and is experiencing increased demand for its medical device testing services as well.
Patients undergoing treatment for advanced head and neck cancers may respond well to the addition of gefinitib to chemotherapy, according to a study sponsored by the Eastern Cooperative Oncology Group and chaired by Ethan Argiris, M.D., associate professor of medicine, University of Pittsburgh School of Medicine, and co-leader of the Head and Neck Cancer Program of the University of Pittsburgh Cancer Institute (UPCI).
The U.S. Department of Agriculture's (USDA) National Veterinary Services Laboratories (NVSL) in Ames, Iowa, has determined that the non-definitive test result reported on July 27 is negative for BSE. Tests conducted by the Veterinary Laboratories Agency in Weybridge, England, are also negative for BSE.
The older adult population in the United States is rapidly increasing, with 10,000 Americans reaching retirement age every day, but many face barriers when it comes to accessing oral healthcare. According to a survey conducted by Harris Poll on behalf of Oral Health America, more than half of low income older adults have not seen a dentist in the past year, with most citing lack of income or lack of dental insurance as the reason.
› Verified 6 days ago
Gary Wayne Benson, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 5052 W 4th St, Hattiesburg, MS 39402 Phone: 601-268-5995 Fax: 601-264-7426 | |
Kurt Gregory Kratz, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 5052 W 4th St, Hattiesburg, MS 39402 Phone: 601-261-2587 Fax: 601-261-3201 | |
Leigh Anne Strong, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 421 S 28th Ave, Hattiesburg, MS 39401 Phone: 601-579-5261 Fax: 601-579-5257 | |
Pearl Gizelle Myers, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 155 Cross Creek Pkwy, Apt 315, Hattiesburg, MS 39402 Phone: 601-520-4268 | |
Dr. Frederick E Nora, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 5052 W 4th St, Hattiesburg, MS 39402 Phone: 601-268-5995 Fax: 601-261-3201 | |
Lynda Gentchev, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 5052 W 4th St, Hattiesburg, MS 39402 Phone: 601-261-2587 | |
Donald H Gale, M.D. Pathology Medicare: Medicare Enrolled Practice Location: 5052 W 4th St, Hattiesburg, MS 39402 Phone: 601-261-2587 Fax: 601-261-3201 |